Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,400
Closed -$1.75M 77
2024
Q2
$1.75M Hold
15,400
0.76% 41
2024
Q1
$2.14M Hold
15,400
0.9% 35
2023
Q4
$1.91M Hold
15,400
0.86% 35
2023
Q3
$1.44M Hold
15,400
0.68% 44
2023
Q2
$1.98M Hold
15,400
0.91% 33
2023
Q1
$1.79M Hold
15,400
0.86% 36
2022
Q4
$1.74M Hold
15,400
0.83% 34
2022
Q3
$1.24M Hold
15,400
0.68% 45
2022
Q2
$1.15M Buy
15,400
+7,700
+100% +$703K 0.6% 51
2022
Q1
$985K Hold
7,700
0.45% 67
2021
Q4
$1.03M Hold
7,700
0.45% 65
2021
Q3
$1.05M Hold
7,700
0.49% 59
2021
Q2
$822K Buy
7,700
+2,400
+45% +$230K 0.38% 72
2021
Q1
$476K Buy
+5,300
New +$498K 0.23% 81

Other funds holding DXCM

Barbara Oil Co's DXCM Position: Q3 2024 in Review

Barbara Oil Co sold out of DexCom (DXCM) in Q3 2024, closing a stake of 15,400 shares — an estimated $1.75M sold.

Barbara Oil Co first reported a position in DXCM in Q1 2021 and held it in 14 quarters. The position peaked at $2.14M in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Barbara Oil Co reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Barbara Oil Co sold 15,400 DexCom shares in Q3 2024, an estimated $1.75M.
  • Barbara Oil Co first reported a position in DexCom in Q1 2021 and held it in 14 quarters.
  • Barbara Oil Co's DexCom position peaked at $2.14M in Q1 2024.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Barbara Oil Co's 13F filing for Q3 2024, filed 14 Nov 2024.